ABSTRACT
Objective:
To investigate the
clinical efficacy of ultrasound-guided mammotomy versus conventional
surgery in the
treatment of benign
breast tumors.
Methods:
Sixty
patients with benign
breast tumors who received
treatment in Jiamusi Central
Hospital from September 2018 to September 2019 were included in this study. They were randomly assigned to undergo either conventional
surgery (
control group, n = 30) or ultrasound-guided mammotomy (
treatment group, n = 30). Intraoperative
blood loss,
operative time, incision length, and the
incidence of
complications were compared between the two groups.
Results:
Intraoperative
blood loss,
operative time, and incision length in the
treatment group were (4.25 ± 1.23) mL, (15.36 ± 3.21) minutes, (0.41 ± 0.05) cm, respectively, which were significantly lower or shorter than those in the
control group [(10.75 ± 2.12) mL, (29.68 ± 7.23) minutes, (2.9 ± 0.8) cm, t = 14.526, 9.915, 17.015, all P < 0.05]. In the
treatment group, the
incidence of
complications was 3.33% (local
hematoma n = 1,
skin depression n = 0, flap
necrosis n = 0, postoperative
bleeding n = 0), which was significantly lower that 23.00% in the
control group (local
hematoma n = 2,
skin depression n = 1, flap
necrosis n = 1, postoperative
bleeding n = 3, χ2 = 5.192, P < 0.05).
Conclusion:
Compared with the traditional
treatment, ultrasound-guided minimally invasive
mastectomy is more effective in the
treatment of benign
breast tumors.